Searchable abstracts of presentations at key conferences in endocrinology

ea0056oc14.5 | What is new in gestational and type 1 diabetes? | ECE2018

Type 1 diabetes mellitus: defining the best cut-off points of arterial stiffness for predicting cardiovascular risk according to the Steno Type 1 Risk Engine

Cano Albert , Llaurado Gemma , Fabregas Lara Albert , Mazarico Isabel , Gonzalez-Sastre Montserrat , Gonzalez-Clemente Jose Miguel

Background: Cardiovascular disease (CVD) is the leading cause of death in persons with type 1 diabetes (T1DM). However, there are no CVD-risk prediction models for this population in widespread use and those developed from general population and type 2 diabetes have been shown to underestimate CVD-risk in T1DM. Recently, the Steno Type 1 Risk Engine (ST1RE) was developed for predicting CVD in a cohort of T1DM persons without clinical CVD. We investigate the relationship betwee...

ea0081ep284 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Factors affecting glycemic outcomes using closed-loop systems in real-world

Fabregas Lara Albert , Andujar David Subias , Gregori Ana Romero , Luchtenberg Maria Florencia , Palomares Albert Cano , Mazarico Isabel , Rigla Mercedes

Aims: To evaluate real-world efficacy of closed-loop systems (CLS) (MinimedTM 780G, DBLG1 -Diabeloop- and Control-IQTM Tandem) as well as to assess those predictive factors related with the achievement of near-normal glycemic control.Methods: A prospective, longitudinal, and observational study was performed. It included T1D adults who initiated CLS between April and December 2021 in our hospital and provided data for ≧3 months (...